Conditions of Participation
for Intermediate Care Facilities for Individuals with Intellectual
Disabilities (ICFs-IID) (CMS-10777)
New
collection (Request for a new OMB Control Number)
No
Regular
06/30/2021
Requested
Previously Approved
36 Months From Approved
17,316
0
114,478
0
0
0
Individuals residing in congregate
settings, regardless of health or medical conditions, are at
greater risk of acquiring infections, and many clients of
Intermediate Care Facilities for Individuals with Intellectual
Disabilities (ICFs-IID) face higher risk of severe illness due to
age, disability, or underlying health conditions. Currently, the
United States (U.S.) is responding to a public health emergency of
respiratory disease caused by a novel coronavirus that has now been
detected in more than 190 countries internationally, all 50 States,
the District of Columbia, and all U.S. territories. The virus has
been named “severe acute respiratory syndrome coronavirus 2”
(SARS-CoV-2), and the disease it causes has been named “coronavirus
disease 2019” (COVID-19). On January 30, 2020, the International
Health Regulations Emergency Committee of the World Health
Organization (WHO) declared the outbreak a “Public Health Emergency
of International Concern.” On January 31, 2020, pursuant to section
319 of the Public Health Service Act (PHSA) (42 U.S.C. 247d), the
Secretary of the Department of Health and Human Services
(Secretary) determined that a public health emergency (PHE) exists
for the United States to aid the nation’s health care community in
responding to COVID-19 (hereafter referred to as the PHE for COVID
19). On March 11, 2020, the WHO publicly declared COVID-19 a
pandemic. On March 13, 2020, the President of the United States
declared the COVID-19 pandemic a national emergency. The January
31, 2020 determination that a PHE for COVID-19 exists and has
existed since January 27, 2020, lasted for 90 days, and was renewed
on April 21, 2020; July 23, 2020; October 2, 2020; and January 7,
2021. Given the new and emerging qualities of COVID-19 disease,
vaccines, and treatments we recognize that education and offering
of the vaccine to clients and staff is critical. The vaccine may be
offered and provided directly by the ICF-IID or indirectly, such as
through a local health department, pharmacy, or doctor’s office.
Vaccines may be administered onsite or at other appropriate
locations. Implementation of COVID-19 education and vaccination
programs in ICFs-IID will help protect clients and staff, allowing
an eventual return to more normal routines, including timely
preventive health care; family, caregiver and community visitors;
and group and individual activities.
US Code:
42
USC 1396d Name of Law: Social Security Act
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.